← back to search

Dominik Hartl

University of Basel · CH
Area of research
Immunology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Immune Response and Inflammation, Neonatal Respiratory Health Research, Cystic Fibrosis Research Advances, and Immune cells in cancer.
h-index
67
citations
15,390
works
267
NIH funding
primary concept
email

Recent publications

The Role of Data Monitoring Committees in drug research
Drug Discovery Today 2025cited by 1position: contributordoi
Arginase 1<sup>+</sup> IL‐10<sup>+</sup> polymorphonuclear myeloid‐derived suppressor cells are elevated in patients with active pemphigus and correlate with an increased Th2/Th1 response
Experimental Dermatology 2021cited by 8position: middledoi
Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis
Nature Communications 2020cited by 269position: middledoi
Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans
Nature Neuroscience 2019cited by 213position: middledoi
Visualization and quantification of <i>in vivo</i> homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer
Theranostics 2019cited by 44position: middledoi
Temporal Dynamics of Reactive Oxygen and Nitrogen Species and NF-κB Activation During Acute and Chronic T Cell–Driven Inflammation
Molecular Imaging and Biology 2019cited by 11position: middledoi
Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine
Journal of Innate Immunity 2018cited by 133position: firstdoi
The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size
EMBO Reports 2018cited by 105position: middledoi
Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis
Journal of Cystic Fibrosis 2018cited by 38position: middledoi
The fungal ligand chitin directly binds and signals inflammation dependent on oligomer size and TLR2
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 1position: middledoi
Human NACHT, LRR, and PYD domain–containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
Journal of Allergy and Clinical Immunology 2017cited by 130position: middledoi
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis
Mycopathologia 2017cited by 62position: middledoi
CXCR1 Regulates Pulmonary Anti-&lt;b&gt;&lt;i&gt;Pseudomonas&lt;/i&gt;&lt;/b&gt; Host Defense
Journal of Innate Immunity 2016cited by 27position: lastdoi
Increased Risk of Interstitial Lung Disease in Children with a Single R288K Variant of ABCA3
Molecular Medicine 2016cited by 27position: middledoi
Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
PLoS Pathogens 2015cited by 658position: lastdoi
Pathogenic Fungi Regulate Immunity by Inducing Neutrophilic Myeloid-Derived Suppressor Cells
Cell Host & Microbe 2015cited by 119position: lastdoi
Differential neutrophil activation in viral infections: Enhanced <scp>TLR</scp>‐7/8‐mediated <scp>CXCL</scp>8 release in asthma
Respirology 2015cited by 51position: middledoi
Surfactant proteins in pediatric interstitial lung disease
Pediatric Research 2015cited by 34position: middledoi
RNA and Imidazoquinolines Are Sensed by Distinct TLR7/8 Ectodomain Sites Resulting in Functionally Disparate Signaling Events
The Journal of Immunology 2014cited by 45position: middledoi
Characterization of rapid neutrophil extracellular trap formation and its cooperation with phagocytosis in human neutrophils
Discoveries 2014cited by 25position: middledoi
Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for <i>Pseudomonas aeruginosa</i> Infection in Cystic Fibrosis Lung Disease
The Journal of Immunology 2013cited by 127position: lastdoi
Modified Foxp3 mRNA protects against asthma through an IL-10–dependent mechanism
Journal of Clinical Investigation 2013cited by 110position: middledoi
Inhalation Treatment with Glutathione in Patients with Cystic Fibrosis. A Randomized Clinical Trial
American Journal of Respiratory and Critical Care Medicine 2013cited by 77position: middledoi
Functional TLR5 Genetic Variants Affect Human Colorectal Cancer Survival
Cancer Research 2013cited by 67position: middledoi
Innate immunity in cystic fibrosis lung disease
Journal of Cystic Fibrosis 2012cited by 223position: firstdoi
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation
BMC Pulmonary Medicine 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas Hector · University of Tübingen7 papers (2012–2017)Matthias Griese · Ludwig-Maximilians-Universität München4 papers (2012–2016)Alexander N.R. Weber · German Cancer Research Center4 papers (2013–2020)Ralf Zarbock · Ludwig-Maximilians-Universität München3 papers (2012–2016)Matthias Kappler · Ludwig-Maximilians-Universität München3 papers (2013–2016)Hasan Halit Öz · University of Tübingen3 papers (2016–2019)Rupert Handgretinger · University College London3 papers (2013–2021)Manfred Kneilling · University of Tübingen3 papers (2016–2019)Kamran Ghoreschi · Clinical Research Center for Hair and Skin Science3 papers (2019–2021)Nikolaus Rieber · Technical University of Munich3 papers (2013–2015)Charalampos Aslanidis · University of Regensburg2 papers (2015–2016)Sascha N. Klimosch · Geistlich Pharma (Switzerland)2 papers (2013–2014)Iris Schäfer · University of Tübingen2 papers (2013–2021)Andrea Schams · Ludwig-Maximilians-Universität München2 papers (2015–2016)Davide Neri · University of Tübingen2 papers (2013–2021)Gerd Döring · Royal College of Surgeons in Ireland2 papers (2012–2013)Peter Lohse · Ludwig-Maximilians-Universität München2 papers (2015–2016)Thomas Wittmann · Ludwig-Maximilians-Universität München2 papers (2015–2016)Julie Laval · Department of Science,Technology and Innovation2 papers (2016–2018)Winfried Baden · University of Tübingen2 papers (2015–2016)